The technology developed by Dolosys GmbH enables automatic measurement of specific pain reflexes and thus provides precise feedback about nociceptive and analgesic processes in the brain and spinal cord.
In this way objective information about the extent of the prevailing pain control can be obtained independently of the patient and the individual pain therapy can be optimised.
Dolosys GmbH is a medical technology company focused on the development and manufacture of devices for objective measurement of pain and pain control. |
As a spin-off from the Charité - Universitätsmedizin Berlin, the company maintains close ties with current research as well as the realities of everyday clinical practice. Read more |
The Paintracker is a handy monitoring device to determine the analgesic depth needed for patients based on the pain reflex technique. The effects of pain therapy can therefore be measured using an objective parameter and concrete treatment recommendations can be derived from these measurements. |
![]() Read more |
Non-communicative patients in particular require a technique to determine possible pain and the prevailing analgesia. Inadequate analgesia can be hazardous for patients due to agitation and stress responses, for example. |
Excessive analgesic therapy can also be harmful due to amplified dose-dependent adverse reactions to the analgesics, for example. Both can increase mortality and morbidity and lead to rising therapy costs. Read more |
Participation: 1ères Journées de Neurophysiologie Clinique (JNC)
From 29 June to 1 July 2016 we will be exhibiting at the 1ères Journées de Neurophysiologie Clinique (JNC) of the Societe de Neurophysiologie Clinique de Langue Francaise (SNCLF).
New for intensive care stations: SSEP Diagnostics with Paintracker
The possibility of using SSEP Diagnostics for assessing the prognosis of comatose patients expands the scope of functionality of the Paintracker by yet another important tool for intensive care stations.